Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy

References

Page 1

	Year	Citations
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation Mary E. Charlson, Peter Pompei, Kathy L. Aleš, Journal of Chronic Diseases Prognostic AssessmentLongitudinal StudiesPrognostic ComorbidityRetrospective Cohort StudyPsychiatry	1987	48.8K
The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients Jean Klášterský, Marianne Paesmans, Edward Rubenstein, Journal of Clinical Oncology	2000	1.1K
Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R Michael Neely, Michael G. van Guilder, Walter M. Yamada, Therapeutic Drug Monitoring	2012	465
Clinical Pharmacokinetics of Teicoplanin Alison Wilson Clinical Pharmacokinetics Medicinal ChemistryPharmacologyClinical PharmacologyClinical PharmacokineticsMedicine	2000	241
In vitro activity and human pharmacokinetics of teicoplanin L. Verbist, B Tjandra-Maga, B Hendrickx, Antimicrobial Agents and Chemotherapy Pharmaceutical ScienceAntimicrobial SusceptibilityAntibioticsHuman PharmacokineticsMedicine	1984	149
Teicoplanin in Patients with Acute Leukaemia and Febrile Neutropenia Federico Pea, Pierluigi Viale, Anna Candoni, Clinical Pharmacokinetics Hematological MalignancyAcute LeukaemiaMedicineHematologyPathology	2004	84
Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis Adrian Brink, Guy A. Richards, R.R. Cummins, International Journal of Antimicrobial Agents Transfusion MedicinePatient SafetySepsisSepsis PhenotypingClinical Chemistry	2008	81
Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients Jason A. Roberts, Andrew Udy, Paul Jarrett, Journal of Antimicrobial Chemotherapy	2015	70
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study Jason A. Roberts, Veronique Stove, Jan J. De Waele, International Journal of Antimicrobial Agents Therapeutic Drug MonitoringBiochemistryMedicineDali StudyDrug Monitoring	2014	70
Population pharmacokinetic study of teicoplanin in severely neutropenic patients Olivier Lortholary, Michel Tod, N. Rizzo, Antimicrobial Agents and Chemotherapy Neutropenic PatientsInterindividual VariabilitiesPharmacologyHematologyLaboratory Medicine	1996	67

Page 1